You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 125 No. 5, May 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on Web of Science (27)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Renal Allograft Rejection

An Analysis of Lysozymuria, Serum Complement, Lymphocyturia, and Heterophil Antibodies

Isam H. Shehadeh, MD; Charles B. Carpenter, MD; Clyde H. Monterio, MD; John P. Merrill, MD

Arch Intern Med. 1970;125(5):850-857.


Abstract

Daily determinations of urinary lysozyme levels, serum β1C (C3) and β1E (C4)globulin concentrations, number of small mononucleated cells in the urinary sediment, and serum heterophil-antibody titers were carried out in 22 patients undergoing renal allotransplantation in order to determine which of these alterations are related to rejection episodes. Small mononuclear cells appeared in the urinary sediment at irregular intervals and displayed no relationship to onset of rejection. Similarly, heterophil-antibody titers rose in relation to only half the episodes of acute rejection, and similar fluctuations were observed in six of 11 patients who did not undergo acute rejection reactions. Urinary lysozyme excretion, on the other hand, was a sensitive indicator of renal tubular damage, and instability of serum complement levels occurred during clinically diagnosed rejection episodes.



Author Affiliations

Boston

From the Department of Medicine, Peter Bent Brigham Hospital, and Harvard Medical School, Boston. Dr. Shehadeh is a Commonwealth Fund Fellow. Dr. Carpenter is a recipient of a National Institutes of Health Career Research Development Award. Dr. Merrill is an investigator of the Howard Hughes Medical Institute, Miami, Fla.


Footnotes

Received for publication Sept 24, 1969; accepted Nov 18.

Read in part before the 81st annual meeting of the American Federation for Clinical Research, Atlantic City, NJ, May 5, 1968.

Reprint requests to 721 Huntington Ave, Boston 02115 (Dr. Carpenter).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.